binding arm in even rounds). The selection reaction was initiated by bringing the sample to 20 µL total volume containing 70 mM HEPES, pH 7.5, 1 mM or 100 µM or 10 µM azido-AYA or azido-GPYSGN peptide (added from a stock solution of 50 mM peptide in DMF, 1 mM peptide in 2% aqueous DMF, or 100 µM peptide in 0.2% aqueous DMF), each of 40 mM MgCl 2 and 20 mM MnCl 2 if included, 1 mM ZnCl 2 , and 150 mM NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol precipitation.
Procedure for CuAAC capture step in round 1. The precipitated selection sample was brought to 20 µL total volume containing 200 pmol of DNA splint for capture, 300 pmol of 49 nt 3-alkyne capture oligonucleotide, 50 mM HEPES, pH 7.5, 150 mM NaCl, 2.8 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA), 0.8 mM sodium ascorbate, and 0.4 mM CuSO 4 . Concentrations of THPTA, sodium ascorbate, and CuSO 4 were optimized through preliminary experiments (not shown). The three reagents were added from 28 mM (10), freshly prepared 20 mM (25), and 4 mM (10) stock solutions, respectively; the three reagents were mixed together and then added at once to the other components. The sample was incubated at 37 °C for 1 h and separated by 8% PAGE. Including an annealing step before adding the THPTA, sodium ascorbate, and CuSO 4 did not increase the yield of the capture reaction.
Procedure for CuAAC capture step in subsequent rounds. The precipitated selection sample was brought to 20 µL total volume containing 50 pmol of DNA splint for capture, 100 pmol of 16 nt (even rounds) or 49 nt (odd rounds) 3-alkyne capture oligonucleotide, 50 mM HEPES, pH 7.5, 150 mM NaCl, 2.8 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA), 0.8 mM sodium ascorbate, and 0.4 mM CuSO 4 . THPTA, sodium ascorbate, and CuSO 4 were added from 28 mM (10), freshly prepared 20 mM (25), and 4 mM (10) stock solutions, respectively; the three reagents were mixed together and then added at once to the other components. The sample was incubated at 37 °C for 1 h and separated by 8% PAGE.
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the PAGE-separated capture product, 200 pmol of 5-phosphorylated forward primer, 50 pmol of reverse primer, 20 nmol of each dNTP, and 10 µL of 10 Taq polymerase buffer (1 = 20 mM Tris-HCl, pH 8.8, 10 mM (NH 4 ) 2 SO 4 , 10 mM KCl, 2 mM MgSO 4 , and 0.1% Triton X-100). This sample was cycled 10 times according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase was removed by phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 5-phosphorylated forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32 P-dCTP (800 Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. The sample was separated by 8% PAGE.
Selections with 5-ImpDNA substrates
Procedure for ligation and 5-phosphorylation steps in round 1. A 50 µL sample containing 1 nmol of DNA pool, 1 mM ATP, 1 T4 PNK buffer A, and 10 units of T4 polynucleotide kinase (Fermentas) was incubated at 37 °C for 2.5 h. T4 polynucleotide kinase was removed by phenol/chloroform extraction followed by ethanol precipitation. The sample was dissolved in 20 µL of 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA containing 1.2 nmol of DNA splint and 1.5 nmol of DNA substrate and annealed by heating at 95 °C for 3 min and cooling on ice for 5 min. The ligation reaction was initiated by bringing the sample to a final volume of 40 µL containing 1 T4 DNA ligase buffer and 5 units of T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h, and T4 DNA ligase was inactivated by heating at 65 °C for 30 min. To avoid adenylylation of the 5-phosphorylated DNA substrate by T4 DNA ligase, the 5-phosphate was incorporated onto the DNA substrate (now attached to the DNA pool) after the ligation step. The ligation product was 5-phosphorylated in 50 µL volume containing 1 mM ATP, 1 T4 PNK buffer A, and 10 units of T4 polynucleotide kinase (Fermentas). The sample was incubated at 37 °C for 5 h and purified by 8% PAGE.
Procedure for ligation and 5-phosphorylation steps in subsequent rounds. A 17 µL sample containing the PCR-amplified DNA pool (~5-10 pmol), 50 pmol of DNA splint, and 100 pmol of DNA substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The ligation reaction was initiated by bringing the sample to a final volume of 20 µL containing 1 T4 DNA ligase buffer and 1 unit of T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h, and T4 DNA ligase was inactivated by heating at 65 °C for 30 min. The ligation product was 5-phosphorylated in 30 µL volume containing 1 mM ATP, 1 T4 PNK buffer A, and 5 units of T4 polynucleotide kinase (Fermentas). The sample was incubated at 37 °C for 1 h and purified by 8% PAGE.
Procedure for 5-phosphorimidazolide (5-Imp) formation. Immediately prior to performing the selection step, a 25 µL sample containing the 5-phosphorylated ligation product, 100 mM 1-ethyl 3-(3dimethylaminopropyl) carbodiimide (EDC), and 100 mM imidazole (pH 6.0 with HCl) was incubated at room temperature for 2 h. A Micro Bio-Spin P-6 desalting column (Bio-Rad) was prepared by centrifuging at 1000 g for 1 min and rinsing 4 by adding 500 µL of water followed by centrifuging at 1000 g for 1 min. The 25 µL sample was applied to the column and eluted by centrifuging at 1000 g for 4 min. For round 1, the eluant was quantified by NanoDrop. For subsequent rounds, the eluant was dried by SpeedVac.
Procedure for selection step in round 1. Each selection experiment was initiated with 200 pmol of the 5-Imp ligated N 40 pool. A 20 µL sample containing 200 pmol of 5-Imp ligated N 40 pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was initiated by bringing the sample to 40 µL total volume containing 50 mM (-Zn 2+ ) or 70 mM (+Zn 2+ ) HEPES, pH 7.5, 1 mM azido-AYA peptide (added from 50 mM stock solution in DMF), each of 40 mM MgCl 2 , 20 mM MnCl 2 , 1 mM ZnCl 2 if included, and 150 mM NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol precipitation.
Procedure for selection step in subsequent rounds. A 10 µL sample containing the 5-Imp ligated N 40 pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was initiated by bringing the sample to 20 µL total volume containing 50 mM (-Zn 2+ ) or 70 mM (+Zn 2+ ) HEPES, pH 7.5, 1 mM or 100 µM azido-AYA peptide (added from 50 mM peptide in DMF or 1 mM peptide in 2% aqueous DMF), each of 40 mM MgCl 2 , 20 mM MnCl 2 , 1 mM ZnCl 2 if included, and 150 mM NaCl. The sample was incubated at 37 °C for 14 h followed by ethanol precipitation.
Procedure for CuAAC capture step in round 1. The procedure for the 5-pppRNA substrate was used.
Procedure for CuAAC capture step in subsequent rounds. The procedure for the 5-pppRNA substrate was used.
Procedure for PCR. The procedure for the 5-pppRNA substrate was used.
Cloning and screening of individual deoxyribozymes PCR primers used for cloning are listed in Table S1 (the forward cloning primer was same as the forward PCR primer for selection, but without the 5-phosphate). The 10-cycle PCR product from the appropriate selection round was diluted 10 3 -fold. A 50 µL sample was prepared containing 1 µL of the diluted 10-cycle PCR product from the appropriate selection round, 100 pmol of forward cloning primer, 25 pmol of reverse cloning primer, 10 nmol of each dNTP, and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. The sample was separated by 1% agarose gel and extracted using a GeneJET Gel Extraction Kit (Fermentas). The extracted product was quantified by absorbance (A 260 ) and diluted to 4-8 ng/µL. A 1 µL portion of the diluted PCR product was inserted into the pCR2.1-TOPO vector using a TOPO TA cloning kit (Life Technologies). Individual E. coli colonies harboring plasmids with inserts were identified by blue-white screening and grown in LB/amp media. Miniprep DNA was prepared using a GeneJET Plasmid Miniprep Kit (Fermentas) and screened for properly sized inserts by EcoRI digestion and agarose gel analysis. Before sequencing, assays of individual deoxyribozyme clones were performed with PAGE-purified DNA strands prepared by PCR from the miniprep DNA, using the single-turnover assay procedure described in the main text. Table S1 . Oligonucleotides used during the in vitro selection, cloning, and assay procedures. All sequences are written 5 to 3 and are DNA unless indicated explicitly as RNA. The 3-alkyne was introduced using 3-alkyne serinol CPG (Glen Research). In the reverse PCR primer for selection, X denotes the HEG spacer to stop Taq polymerase. a XJ denotes the selection with azido-AYA peptide, pppRNA, and Mg 2+ /Mn 2+ /Zn 2+ . b XK denotes the selection with azido-AYA peptide, pppRNA, and Zn 2+ . c EM1 denotes the selection with azido-GPYSGN peptide, pppRNA, and Mg 2+ /Mn 2+ /Zn 2+ . d EN1 denotes the selection with azido-AYA peptide, ImpDNA, and Mg 2+ /Mn 2+ . e EP1 denotes the selection with azido-AYA peptide, ImpDNA, and Mg 2+ /Mn 2+ /Zn 2+ .
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